Abstract
Flow cytometry is a rapid technique allowing simultaneous analysis of multiple cellular parameters, including DNA content. The technique relies on a single-cell suspension being passed within a stream of sheath fluid through an optically focused excitation light source, either a laser or an arc lamp. The most common excitation wavelength used in flow cytometers is a 488 nm wavelength light from an argon laser. Lasers provide a single wavelength of coherent light while arc lamps produce a mixture of incoherent wavelengths that must be filtered. When a laser light source is used, the amount of light scattered in the forward direction is detected in the forward angle light scatter (FALS) channel and its intensity is roughly proportional to the size of the cells or particles. Light scattered perpendicular to the path of the laser is detected in the side scatter channel (SSC) and its intensity is more closely related to granularity. If the cells have been stained with fluorochromes they will also emit fluorescence intensities at levels that directly correspond to the density of fluorochrome on or within the cell. The fluorescence signal emitted by any specific fluorochrome is collected through separate channel detectors (photomultipliers) by means of a series of optical filters and mirrors that guide the beam of light. In order to simultaneously measure more than one fluorescence signal from any given cell, multiple channels/detectors are used. A more comprehensive resume can be found elsewhere (1).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Shapiro, H. M. Practical Flow Cytometry, 4th Ed., Alan R Liss, ISBN 0-471-41125-6.
Barlogie, B., Raber, M. N., Schuman, J., et al. (1983) Flow cytometry in clinical cancer research. Cancer Res. 43, 3982–3997.
Auer, G. U., Caspersson, T. O., and Wallgren, A. S. (1980) DNA content and survival in mammary cancer. Anal. Quant. Cytol. Histol. 2, 161–165.
Baildam, A. D., Zaloudik, J., Howell, A., et al. (1987) DNA analysis by flow cytometry, response to endocrine treatment and prognosis in advanced carcinoma of the breast. Br. J. Cancer 55, 553–559.
Kallioniomi, O. P., Hietanen, T., Mattila, J., Lentinen, M., Lauslahti, K., and Koivula, T. (1987) Aneuploid DNA cancer and high S-phase fraction of tumour cells are related to poor prognosis in patients with primary breast cancer. Eur. J. Cancer Clin. Oncol. 23, 277–282.
Pinto, A. E., Andre, S., and Soares, J. (1999) Short term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients. J. Clin. Pathol. 52, 604–611.
Bracko, M., Us-Krasovec, M., Cufer, T., Lamovec, J., Zidar, A., and Goehde, W. (2001) Prognostic significance of DNA ploidy determined by high resolution flow cytometry in breast carcinoma. Anal. Quant. Cytol. Histol. 23, 56–66.
Evans, M. P., and Podratz, K. C. (1996) Endometrial neoplasia: prognostic significance of ploidy status. Clin. Obstet. Gynecol. 39, 696–706.
Ozalp, S., Yalcin, O. T., Gulbas, Z., Tanir, H. M., and Minsin, T. (2001) Effect of cellular DNA content on the prognosis of epithelial ovarian cancers. Gynecol. Obstet. Invest. 52, 93–97.
Kimmig, R., Wimberger, P., Hillemanns, P., Kapsner, T., Caspari, C., and Hepp, H. (2002) Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labelled tumor cells. Gynecol. Oncol. 84, 21–31.
Fordham, M. V., Burdge, A. H., Matthews, J., Williams, G., and Cooke, T. (1986) Prostatic carcinoma cell DNA content measured by flow cytometry and its relation to clinical outcome. Br. J. Surg. 73, 400–403.
Wolley, R. C., Schreiber, K., Koss, L. G., Karas, M., and Sherman, A. (1982) DNA distribution in human colon carcinomas and its relationship to clinical behaviour. J. Natl. Cancer Inst. 69, 15–22.
Emdin, S. O., Stenling, R., and Roos, G. (1987) Prognostic value of DNA content in colorectal carcinoma. A flow cytometric study with some methodologic aspects. Cancer 60, 1282–1287.
Lanza, G., Gafa, R., Santini, A., et al. (1998) Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study. Cancer 82, 49–59.
Salud, A., Porcel, J. M., Raikundalia, B., Camplejohn, R. S., and Taub, N. A. (1999) Prognostic significance of DNA ploidy, S-phase fraction, and P-glycoprotein expression in colorectal cancer. J. Surg. Oncol. 72, 167–174.
Deans, G. T., Williamson, K., Heatley, M., et al. (1993) The role of flow cytometry in carcinoma of the colon and rectum. Surg. Gynecol. Obstet. 177, 377–382.
Resnik, E., Trujillo, Y. P., and Taxy, J. B. (1997) Long term survival and DNA ploidy in advanced epithelial ovarian cancer. J. Surg. Oncol. 64, 299–303.
Coley, H. M., Sargent, J. M., Titley, J., and Taylor, C. G. (1999) Lack of prognostic significance of ploidy and S-phase measurements in advanced ovarian cancer. Anticancer Res. 19, 2111–2116.
Duigou, F., Herlin, P., Marnay, J., and Michels, J. J. (2000) Variation of flow cytometric DNA measurement in 1,485 primary breast carcinomas according to guidelines for DNA histogram interpretation. Cytometry 15, 35–42.
Emri, S., Akbulut, H., Zorlu, F., et al. (2001) Prognostic significance of flow cytometric DNA analysis in patients with malignant pleural mesothelioma. Lung Cancer 33, 109–114.
Maillo, A., Diaz, P., Blanco, A., et al. (1999) Proportion of S-phase tumour cells measured by flow cytometry is an independent prognostic factor in meningioma tumors. Cytometry 38, 118–123.
Koester, S. K., Maenpaa, J. U., Wiebe, V. J., et al. (1994) Flow cytometry: potential utility in monitoring drug effects in breast cancer. Breast Cancer Res. Treat. 32, 57–65.
Hedley, D. W., Friedlander, M. L., Taylor, I. W., Rugg, C. A., and Musgrove, E. A. (1984) Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J. Histochem. Cytochem. 31, 1333–1335.
Schultz, D. S. and Zarbo, R. J. (1992) Comparison of eight modifications of Hedleys method for flow cytometric DNA ploidy analysis of paraffin-embedded tissue. Am. J. Clin. Pathol. 98, 291–295.
Alanen, K. A., Klemi, P. J., Joensuu, H., Kujari, H., and Pekkala, E. (1989) Comparison of fresh, ethanol-preserved, and paraffin-embedded samples in DNA flow cytometry. Cytometry 10, 81–85.
Levack, P. A., Mullen, P., Anderson, T. J., Miller, W. R., and Forrest, A. P. M. (1987) DNA analysis of breast tumour fine needle aspirates using flow cytometry. Br. J. Cancer 56, 643–646.
Vindeløv, L. L., Christensen, I. J., Keiding, N., Spang-Thomsen, M., and Nissen, N. I. (1983) Long term storage of samples for flow cytometric DNA analysis. Cytometry 3, 317–322
Vindeløv, L. L., Christensen, I. J., Nissen, N. I. (1983) A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3, 323–327.
Soule, H. D., Vazquez, J., Long, A., Albert, S., and Brennan, M. T. (1973) A human cell line from a pleural effusion derived from a breast carcinoma. J. Nat. Cancer Inst. 51, 1409–1413.
Langdon, S. P., Lawrie, S. S., Hay, F. G., et al. (1988) Characterisation and properties of nine human ovarian cancer cell lines. Cancer Res. 48, 6166–6172.
Vindeløv, L. L., Christensen, I. J., and Nissen, N. I. (1983) Standardisation of high-resolution flow cytometric DNA analysis by the simultaneous use of chicken and trout red blood cells as internal reference standards. Cytometry 3, 328–331.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Mullen, P. (2004). Flow Cytometric DNA Analysis of Human Cancer Cell Lines. In: Langdon, S.P. (eds) Cancer Cell Culture. Methods in Molecular Medicine™, vol 88. Humana Press. https://doi.org/10.1385/1-59259-406-9:247
Download citation
DOI: https://doi.org/10.1385/1-59259-406-9:247
Publisher Name: Humana Press
Print ISBN: 978-1-58829-079-3
Online ISBN: 978-1-59259-406-1
eBook Packages: Springer Protocols